Varian Medical Systems, Inc. (VAR): Price and Financial Metrics

Varian Medical Systems, Inc. (VAR)

Today's Latest Price: $174.66 USD

0.25 (0.14%)

Updated Dec 4 7:00pm

Add VAR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

VAR Stock Summary

  • VAR has a higher market value than 88.16% of US stocks; more precisely, its current market capitalization is $15,919,604,028.
  • VAR's went public 32.93 years ago, making it older than 89.53% of listed US stocks we're tracking.
  • The price/operating cash flow metric for Varian Medical Systems Inc is higher than 87.16% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Varian Medical Systems Inc are ZBRA, JKHY, BRKR, DOX, and ABMD.
  • VAR's SEC filings can be seen here. And to visit Varian Medical Systems Inc's official web site, go to

VAR Stock Price Chart Interactive Chart >

Price chart for VAR

VAR Price/Volume Stats

Current price $174.66 52-week high $176.19
Prev. close $174.41 52-week low $89.62
Day low $174.27 Volume 587,290
Day high $174.68 Avg. volume 1,022,114
50-day MA $172.82 Dividend yield N/A
200-day MA $142.01 Market Cap 15.96B

Varian Medical Systems, Inc. (VAR) Company Bio

Varian Medical Systems designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The company was founded in 1948 and is based in Palo Alto, California.

VAR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$174.66$32.8 -81%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Varian Medical Systems Inc. To summarize, we found that Varian Medical Systems Inc ranked in the 16th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Varian Medical Systems Inc, consider:

  • Its compound free cash flow growth rate, as measured over the past 5.79 years, is 0% -- higher than only 24.98% of stocks in our DCF forecasting set.
  • VAR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 47.25% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Varian Medical Systems Inc has a reliance on debt greater than only 20.21% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Varian Medical Systems Inc? See FGEN, IDXX, TFX, BSX, and LMNX.

VAR Latest News Stream

Event/Time News Detail
Loading, please wait...

VAR Latest Social Stream

Loading social stream, please wait...

View Full VAR Social Stream

Latest VAR News From Around the Web

Below are the latest news stories about Varian Medical Systems Inc that investors may wish to consider to help them evaluate VAR as an investment opportunity.

Radiotherapy Market Size (2020-2027) and Top Companies- Varian Medical Systems, Inc., Elekta AB, Accuray, Inc., CIVCO Medical Solutions, Brainlab AG

According to Data Bridge Market Research the radiotherapy market is witnessing a significant growth in developing economies due to factors such as increasing geriatric population, busy and unhealthy lifestyle, rising occurrences of cancer and surging investment for the development of

OpenPR | September 29, 2020

Oncology Information System Market Outlooks 2020: Technological Advancement, Industry Analysis, Market Demand, Growth rate and Market Forecasts to 2027 | Varian Medical Systems, Elekta AB, Altos Solutions, Cerner Corporation, etc

Technological advancements in OIS, associated advantages of OIS over conventional record maintenance, integration of oncology information systems for the treatment rare cancer types and surge in prevalence of cancer worldwide are key factors contributing to high CAGR of Oncology Information

OpenPR | September 29, 2020

Telix Pharma teams up with Varian in advanced prostate imaging (OTCMKTS:TLPPF)

Telix Pharmaceuticals Limited (OTC:TLPPF) will collaborate with Varian Medical Systems (NYSE:VAR) to evaluate the use of advanced prostate cancer imaging w

Seeking Alpha | September 3, 2020

Varian Medical Systems reports Q3 results

Varian Medical Systems (VAR): Q3 Non-GAAP EPS of $0.78; GAAP EPS of $0.67.Revenue of $694.3M (-15.9% Y/Y)Press Release...

Seeking Alpha | August 3, 2020

Siemens Healthineers plans two-step 7.5 billion euro capital hike for Varian acquisition: sources

Siemens Healthineers plans a two-step capital increase to raise 7.5 billion euros (US$8.80 billion) via share placements to help finance its acquisition of Varian Medical Systems , sources close to the matter said on Monday.

Channel NewsAsia | August 3, 2020

Read More 'VAR' Stories Here

VAR Price Returns

1-mo 0.74%
3-mo 0.47%
6-mo 30.15%
1-year 26.10%
3-year 57.29%
5-year 116.81%
YTD 22.99%
2019 25.33%
2018 1.94%
2017 23.80%
2016 11.11%
2015 -6.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.859 seconds.